Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) EBIT Margin (2016 - 2026)

Skinvisible's EBIT Margin history spans 16 years, with the latest figure at 2283.38% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 169148.0% to 2283.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 2481.57%, a 46637.0% increase, with the full-year FY2025 number at 2481.57%, up 46637.0% from a year prior.
  • EBIT Margin hit 2283.38% in Q4 2025 for Skinvisible, down from 2121.14% in the prior quarter.
  • Over the last five years, EBIT Margin for SKVI hit a ceiling of 58.35% in Q4 2021 and a floor of 3974.86% in Q4 2024.
  • Historically, EBIT Margin has averaged 1807.54% across 5 years, with a median of 2272.79% in 2023.
  • Biggest five-year swings in EBIT Margin: soared 282876bps in 2021 and later plummeted -242547bps in 2023.
  • Tracing SKVI's EBIT Margin over 5 years: stood at 58.35% in 2021, then plummeted by -4135bps to 2354.32% in 2022, then decreased by -16bps to 2730.76% in 2023, then plummeted by -46bps to 3974.86% in 2024, then skyrocketed by 43bps to 2283.38% in 2025.
  • Business Quant data shows EBIT Margin for SKVI at 2283.38% in Q4 2025, 2121.14% in Q3 2025, and 2724.74% in Q2 2025.